Received Mar 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
they are now giving it to many adults; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in unspecified number of patients who received MMR (Priorix) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate age at vaccine administration (Verbatim: they are now giving it to many adults). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date : 05-MAR-2025 This case is for unspecified number of adult patients. A pharmacist contacted us via chat and mentioned that the Priorix insert said subcutaneous, but referred to children only. As they were giving it to many adults, many regulatory bodies were saying intramuscular or subcutaneous, which led to Inappropriate age at vaccine administration.